Kieffer Tara Lynn Insider Trades

Insider Trading History

Track insider trading activity for Kieffer Tara Lynn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $436k 37,182 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.8k 6,562 shares
$13.84
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $398k 33,925 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.4k 3,257 shares
$14.25
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $359k 30,620 shares
Last Trade
Dec 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$30k 2,106 shares
$14.23
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $384k 32,726 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.6k 753 shares
$14.12
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $1.17M 100,000 shares
Last Trade
Nov 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.37M 100,000 shares
$13.66
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $432k 36,805 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 7,500 shares
$5.86
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $393k 33,479 shares
Last Trade
Feb 12, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.6k 3,326 shares
$5.59
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $344k 29,305 shares
Last Trade
Dec 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.4k 2,283 shares
$8.06
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $371k 31,588 shares
Last Trade
Dec 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.48k 753 shares
$8.60
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $950k 81,000 shares
Last Trade
Nov 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$715k 81,000 shares
$8.83
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $379k 32,341 shares
Last Trade
Jun 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.6k 7,266 shares
$12.33
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $476k 40,580 shares
Last Trade
Feb 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.9k 3,320 shares
$12.33
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Chief Product Strategy Officer
Holding Value $465k 39,607 shares
Last Trade
Feb 12, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.1k 973 shares
$12.41
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Prod. Strat. & Dev
Holding Value $437k 37,260 shares
Last Trade
Dec 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.5k 2,125 shares
$9.63
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Prod. Strat. & Dev
Holding Value $462k 39,385 shares
Last Trade
Dec 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.15k 753 shares
$9.49
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Prod. Strat. & Dev
Holding Value $974k 83,000 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 83,000 shares
$8.99
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Product Dev.
Holding Value $471k 40,138 shares
Last Trade
Feb 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$355k 6,725 shares
$52.77
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Product Dev.
Holding Value $303k 25,866 shares
Last Trade
Dec 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.1k 498 shares
$44.33
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Product Dev.
Holding Value $469k 40,000 shares
Last Trade
Nov 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.63M 58,500 shares
$45.00
$11.73
Enanta Pharmaceuticals
Enanta Pharmaceuticals ENTA
Sr. Vp, New Product Dev.
Holding Value $98.7k 8,416 shares
Last Trade
Feb 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.5k 1,616 shares
$60.96
$11.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up